Abciximab (C7E3), a chimeric mouse/human monoclonal antibody, is a glycoprotein (GP) IIb/IIIa inhibitor. Abciximab inhibits platelet aggregation and leucocyte adhesion by binding to the glycoprotein IIb/IIIa, vitronectin and Mac-1 receptors.
Purity:
99.5%
CAS Number:
[143653-53-6]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted
